Shaanxi Panlong Pharmaceutical Group Co., Ltd (SHE: 002864), a leading pharmaceutical company based in China, has announced the signing of a cooperation framework agreement with Xi’an Medical University. This strategic partnership will see the two entities leveraging their respective resources to collaborate across various fields.
Under the agreement, Panlong Pharma will establish a Class 2A modern rehabilitation hospital in conjunction with Xi’an Medical University, which is provisionally named Xi’an Medical University Affiliated Qinling Hospital. Additionally, the partners will work together to construct a new campus for the Nursing and Rehabilitation College of Xi’an Medical University. Panlong Pharma also intends to set up a platform for industry-university research cooperation with the second-level colleges and affiliated hospitals of Xi’an Medical University.
To further support talent development, Panlong Pharma plans to endow a special medical fund at Xi’an Medical University with an annual contribution of RMB 1 million. This initiative aims to bolster financial support for educational and research programs and extend their collaborative efforts in poverty alleviation through industry-university research partnerships.- Flcube.com
